Number of the records: 1  

lieky skúšané

  1. SYSd015507
    LBL
      
    00000cy--a2200000n--4500
    005
      
    20250606214529.7
    008
      
    920407|-|anznnbabn-----------|-a|a------
    040
      
    $b slo $a DNLM $d BA006 $d BA006 $d BA006
    065
      
    $a D26.371
    066
      
    $a 01 $c 03
    150
      
    $a lieky skúšané $x AD $x AE $x AN $x CH $x CL $x CS $x EC $x HI $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $2 slo
    450
      
    $w v $a Investigational Drug $2 eng
    450
      
    $w v $a Investigational New Drug $2 eng
    450
      
    $w v $a Investigational New Drugs $2 eng
    450
      
    $w v $a liek skúšaný $2 slo
    450
      
    $w v $a liek skúšaný nový $2 slo
    450
      
    $w v $a lieky skúšané nové $2 slo
    550
      
    $7 sllk_us_auth*d002986 $Y Clinical Trials as Topic $w p $a skúšanie klinické ako téma
    550
      
    $7 sllk_us_auth*d004341 $Y Drug Evaluation $w p $a hodnotenie lieku
    550
      
    $7 sllk_us_auth*d017387 $Y Investigational New Drug Application $w p $a žiadosť o povolenie klinického skúšania nového lieku
    550
      
    $7 sllk_us_auth*d017277 $Y Drug Approval $w b $a registrácia lieku
    665
      
    $a 90 $2 eng
    665
      
    $a Clinical Trials (1966-1989) $2 eng
    665
      
    $a Drug Evaluation (1974-1989) $2 eng
    665
      
    $a Drugs (1966-1989) $2 eng
    680
    9-
    $i Drugs which have received FDA approval for human testing but have yet to be approved for commercial marketing. This includes drugs used for treatment while they still are undergoing clinical trials (Treatment IND). The main heading includes drugs under investigation in foreign countries. $2 eng
    680
      
    $a coordinate with specific drug; not restricted to FDA studies: may be used for investigational drugs in other countries $2 eng
    750
      
    $a Drugs, Investigational $2 eng
    980
      
    $x M
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.